Abstract
Meningiomas originate from the arachnoid layer of the meninges and divided histologically into three grades: benign (grade I), atypical (grade II), and malignant meningiomas (grade III). Genetic alterations in grade I meningiomas include frequent deletions of chromosomal locus 22q12 and NF2 gene mutations and uncommon somatic SMARCB1 and SMARCE1gene mutations; In grade II meningiomas, chromosomal losses occur on 1p, 22q, 14q, 18q, 10, and 6q, and gains on 20q, 12q, 15q, 1q, 9q, and 17q; In grade III meningiomas, losses have been recognized on 6q, 10, and 14q and alterations of PTEN, CDKN2A and CDKN2B genes. Epigenetic alterations in meningiomas include hypermethylation of the tumor suppressor genes p73 in grade I meningiomas and TIMP3 GSTP1, MEG3, HOXA6, HOXA9, PENK, WNK2 and UPK3A genes with an increasing frequency according to grade. Abnormal expression of IGF signaling family genes and Wnt signaling pathway is associated with meningioma progression. MiRNA expression profiling of meningiomas show downregulation of miR-29c-3p, miR-200a, miR-145 and miR- 219-5p and upregulation of miR-21 miR-335 and miR-190a levels. In conclusion, extensive genetic and epigenetic alterations exist in meningiomas that may help assessing prognosi...Continue Reading
Citations
May 19, 2018·International Journal of Radiation Biology·Valentina PinziLaura Fariselli
Oct 4, 2018·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Feb 7, 2019·American Journal of Physiology. Cell Physiology·Yan DongFa-Lin Xu
Mar 26, 2019·American Journal of Medical Genetics. Part a·Rosalie E FernerLarry S Sherman
Jun 18, 2019·British Journal of Neurosurgery·Friso de VriesWouter R van Furth
Jan 18, 2018·Expert Review of Neurotherapeutics·Caroline ApraMichel Kalamarides
Jan 23, 2020·Journal of Pathology and Translational Medicine·Young Suk Lee, Youn Soo Lee
Sep 9, 2017·Oncotarget·Ding CaoJianping Gong
May 20, 2020·International Journal of Cancer. Journal International Du Cancer·Jie DengXiangcai Ruan
Aug 10, 2019·Aging·Yi LiuShaohua Ge
Sep 1, 2019·Acta Neuropathologica Communications·Gerhard JungwirthChristine Jungk
Oct 6, 2020·Frontiers in Oncology·Lu ShenAnwen Shao
Aug 25, 2020·BioMed Research International·Juan WangJian-Huang Wu
May 14, 2019·International Journal of Oncology·Feixiang WuXin Gou
Mar 18, 2020·Briefings in Bioinformatics·Weidun XieYing Liu
Sep 12, 2018·Scientific Reports·Grace CollordUltan McDermott
Jun 15, 2018·Cell Death & Disease·Hongyue ZhangDaling Zhu
Nov 16, 2019·Journal of Neuro-oncology·Anne GuyotFrançois Labrousse
Jul 23, 2020·Reviews in the Neurosciences·Lei WangZhengwen He
Dec 22, 2020·Oncotarget·Ahmad A NazemManuel J Ferreira
Nov 17, 2020·Frontiers in Oncology·Kristin HuntoonSonika Dahiya
Apr 4, 2021·Biomedicines·Christian OgasawaraD Cory Adamson
Apr 4, 2021·Cancers·Rahmina MetaSverre H Torp
May 4, 2021·Frontiers in Oncology·Bing XiaoXingen Zhu
Feb 16, 2021·The Journal of Craniofacial Surgery·Zheng ChenZefu Li
Aug 7, 2021·Contrast Media & Molecular Imaging·Jinhuan LiuFeifei Zeng
Nov 14, 2021·BMC Cancer·Hui XieWei-Cheng Lu
Dec 1, 2021·Journal of Neuro-oncology·Stephanie M RobertJennifer Moliterno
Nov 19, 2021·Neuro-oncology·Farshad NassiriGelareh Zadeh